Safety and Clinical Outcomes of Kanglaite Injection in Combination with Toripalimab and Chemotherapy for Advanced Non-Small Cell Lung Cancer: A Real-World Retrospective Analysis
{{output}}
Introduction: For advanced non-small cell lung cancer (NSCLC) without oncogenic drivers, PD-1 inhibitors combined with chemotherapy represent a standard first-line regimen. However, treatment-related adverse events (TRAEs) and su... ...
